Literature DB >> 22326911

Synthetic 3D multicellular systems for drug development.

Markus Rimann1, Ursula Graf-Hausner.   

Abstract

Since the 1970s, the limitations of two dimensional (2D) cell culture and the relevance of appropriate three dimensional (3D) cell systems have become increasingly evident. Extensive effort has thus been made to move cells from a flat world to a 3D environment. While 3D cell culture technologies are meanwhile widely used in academia, 2D culture technologies are still entrenched in the (pharmaceutical) industry for most kind of cell-based efficacy and toxicology tests. However, 3D cell culture technologies will certainly become more applicable if biological relevance, reproducibility and high throughput can be assured at acceptable costs. Most recent innovations and developments clearly indicate that the transition from 2D to 3D cell culture for industrial purposes, for example, drug development is simply a question of time.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2012        PMID: 22326911     DOI: 10.1016/j.copbio.2012.01.011

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  45 in total

1.  Magnetic assembly of 3D cell clusters: visualizing the formation of an engineered tissue.

Authors:  S Ghosh; S R P Kumar; I K Puri; S Elankumaran
Journal:  Cell Prolif       Date:  2016-02-02       Impact factor: 6.831

2.  Hydrophobic Patterning-Based 3D Microfluidic Cell Culture Assay.

Authors:  Sewoon Han; Junghyun Kim; Rui Li; Alice Ma; Vincent Kwan; Kevin Luong; Lydia L Sohn
Journal:  Adv Healthc Mater       Date:  2018-04-26       Impact factor: 9.933

3.  3 dimensional cell cultures: a comparison between manually and automatically produced alginate beads.

Authors:  R Lehmann; C Gallert; T Roddelkopf; S Junginger; A Wree; K Thurow
Journal:  Cytotechnology       Date:  2015-04-05       Impact factor: 2.058

4.  Microfluidics on the fly: Inexpensive rapid fabrication of thermally laminated microfluidic devices for live imaging and multimodal perturbations of multicellular systems.

Authors:  Megan Levis; Nilay Kumar; Emily Apakian; Cesar Moreno; Ulises Hernandez; Ana Olivares; Fernando Ontiveros; Jeremiah J Zartman
Journal:  Biomicrofluidics       Date:  2019-04-26       Impact factor: 2.800

Review 5.  Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors.

Authors:  Rasheena Edmondson; Jessica Jenkins Broglie; Audrey F Adcock; Liju Yang
Journal:  Assay Drug Dev Technol       Date:  2014-05       Impact factor: 1.738

Review 6.  Screening out irrelevant cell-based models of disease.

Authors:  Peter Horvath; Nathalie Aulner; Marc Bickle; Anthony M Davies; Elaine Del Nery; Daniel Ebner; Maria C Montoya; Päivi Östling; Vilja Pietiäinen; Leo S Price; Spencer L Shorte; Gerardo Turcatti; Carina von Schantz; Neil O Carragher
Journal:  Nat Rev Drug Discov       Date:  2016-09-12       Impact factor: 84.694

Review 7.  The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer.

Authors:  Britta Weigelt; Cyrus M Ghajar; Mina J Bissell
Journal:  Adv Drug Deliv Rev       Date:  2014-01-09       Impact factor: 15.470

8.  Multiphase matrix of silica, culture medium and air for 3D mammalian cell culture.

Authors:  Mika Jokinen; Karen Pittois; Suzanne van den Akker; Inge Gutschoven; Tatu Assmuth; Tapio Metz; Hanna Lehtilä; Pekka Alanne
Journal:  Cytotechnology       Date:  2020-02-19       Impact factor: 2.058

9.  Testing the potency of anti-TNF-α and anti-IL-1β drugs using spheroid cultures of human osteoarthritic chondrocytes and donor-matched chondrogenically differentiated mesenchymal stem cells.

Authors:  Sara Žigon-Branc; Ariana Barlič; Miomir Knežević; Matjaž Jeras; Gordana Vunjak-Novakovic
Journal:  Biotechnol Prog       Date:  2018-03-31

10.  Comparative studies of cellular viability levels on 2D and 3D in vitro culture matrices.

Authors:  M Gargotti; U Lopez-Gonzalez; H J Byrne; A Casey
Journal:  Cytotechnology       Date:  2017-09-18       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.